Latest Financial Performance News

Myer Holdings reports a 1.9% increase in total sales for the second half of fiscal 2025 despite inflationary pressures and operational hurdles at its new distribution centre. The retailer outlines interim logistics solutions and previews its upcoming Growth Strategy.

Oceania Healthcare Limited reported a robust FY25 with a 9.2% rise in sales volume and a 5.8% increase in comprehensive income, underpinned by a successful $500 million debt refinancing and operational enhancements.

BetMakers Technology Group reports a strong FY25 trading update, driven by enhancements to its Apollo racing suite and preparations for the GTX wagering platform launch, signaling robust momentum heading into FY26.

Fortescue Metals Group updates on the Iron Bridge magnetite project, projecting a steady ramp-up to full capacity by FY28 with operational improvements driving production and cost efficiencies.

Ventia Services Group Limited delivered strong financial results for 2024, highlighted by a 12.8% rise in NPATA and a record 92% contract renewal rate, while reaffirming growth guidance despite ongoing ACCC proceedings.

Australian Agricultural Company Limited (AACo) reported a 14% rise in operating profit to $58.4 million for FY25, driven by increased sales volumes and disciplined cost control despite challenging market conditions. The company also marked a significant reduction in statutory loss, signaling improved financial resilience.

Australian Agricultural Company Limited (AACo) reported a robust FY25 operating profit of $58.4 million, driven by increased meat and cattle sales volumes and strategic brand growth despite inflationary pressures.

Australian Agricultural Company Limited (AACo) has reported a robust turnaround in its FY25 results, with significant gains in revenue and profitability driven by higher sales volumes and improved operational efficiency.

Oceania Healthcare reported a 4.1% rise in underlying EBITDA for FY25, driven by strong sales and operational improvements, while launching a new strategic plan focused on growth and efficiency.

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.

Dicker Data reported a 2.9% increase in FY24 gross revenue to $3.37 billion with stable EBITDA, while FY25 starts strong with 17.4% sales growth driven by AI and Windows 10 refresh demand.

Light & Wonder unveiled ambitious growth targets and strategic plans at its 2025 Investor Day, spotlighting strong financial momentum and the integration of Grover Charitable Gaming. The company aims for $1.4 billion consolidated AEBITDA in 2025, underpinned by robust R&D and market leadership.